CTSNet

Cardiac - Pharmacology

Heart Failure with Preserved Ejection Fraction — A Metabolic Disease?

By Aristotle Protopapas

Sep. 21, 2023

0

The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory Support

Feb. 13, 2023

0

Differences in Metabolomic Profiles Between Black and White Women and Risk of Coronary Heart Disease: an Observational Study of Women From Four US Cohorts

By Aristotle Protopapas

Sep. 20, 2022

0

Vascular

Human Coronary Plaque T Cells Are Clonal and Cross-React to Virus and Self

By Aristotle Protopapas

Apr. 19, 2022

0

Basic Science

Heart Failure and Atrial Fibrillation—Chicken or Egg?

By Aristotle Protopapas

Apr. 5, 2022

0

Basic Science

Social Determinants of Cardiovascular Disease

By Aristotle Protopapas

Mar. 4, 2022

0

Coronary Disease

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk

By Aristotle Protopapas

Nov. 9, 2021

0

Vascular

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

By Aristotle Protopapas

Oct. 21, 2021

0

Coronary Disease

Aspirin-Free Strategies in ACS: Is It the Drug or the Stent?

By Aristotle Protopapas

Feb. 21, 2021

0

Valve Disease

Rivaroxaban in Patients With Atrial Fibrillation and a Bioprosthetic Mitral Valve

By Aristotle Protopapas

Nov. 28, 2020

0

Pharmacology

Cardiac Myosin Activation With Omecamtiv Mecarbil in Systolic Heart Failure

By Aristotle Protopapas

Nov. 17, 2020

0

Vascular

Combined Antiplatelet/Anticoagulant Drug for Cardiac Ischemia/Reperfusion Injury

By Aristotle Protopapas

Aug. 18, 2020

0

1 2 3 … 5